Results 81 to 90 of about 2,779,055 (335)
A COMPARATIVE VIEW OF THE LAW, ETHICS, AND POLICIES SURROUNDING MEDICAL AID IN DYING IN THE UNITED STATES AND NETHERLANDS [PDF]
, 2020 This note will compare the state of the law surrounding medical aid in dying in the United States and the Netherlands. Medical aid in dying is currently legal in eight American states and the District of Columbia.3 In all nine United States jurisdictions
Delaney Blakey, Delaney
core +1 more source
Medical idioms for clinical Bayesian network development [PDF]
, 2020 Bayesian Networks (BNs) are graphical probabilistic models that have proven popular in medical applications. While numerous medical BNs have been published, most are presented fait accompli without explanation of how the network structure was developed or justification of why it represents the correct structure for the given medical application.
arxiv +1 more source
Have Arguments For and Against Medical Aid in Dying Stood the Test of Time?
Voices in Bioethics, 2023 Photo ID 129550055 © Katarzyna Bialasiewicz | Dreamstime.com ABSTRACT It has been 26 years since medical aid in dying (“MAiD”) was first legalized in Oregon, and today, about 20 percent of people in the US live in jurisdictions that permit MAiD.
David Hoffman, Emily Beer
semanticscholar +1 more source
Bioethics and the Holocaust [PDF]
, 2022 This open access book offers a framework for understanding how the Holocaust has shaped and continues to shape medical ethics, health policy, and questions related to human rights around the world.
core +1 more source
Terminal anorexia nervosa is a dangerous term: it cannot, and should not, be defined
Journal of Eating Disorders, 2022 A recent article (JED 10:23, 2022) proposed defining terminal anorexia to improve access to palliative and hospice care, and to medical aid in dying for a minority of patients with severe and enduring anorexia nervosa (SE-AN). The authors presented three
Angela S. Guarda +3 more
doaj +1 more source
An Analysis of New York State's Medical Aid in Dying Act (A. 2383A S. 3151)
Voices in Bioethics, 2018 Introduction An amended version of the proposed Medical Aid in Dying Act (A. 2383A S. 3151) was recently filed with the New York State legislature [1].
Michael Dauber
doaj +1 more source
Dy doped BiFeO$_3$ : A Bulk Ceramic with Improved Multiferroic Properties Compared to Nano Counterparts [PDF]
Ceramics International 43 (2017) 9191-9199, 2017 The synthesis as well as structural, multiferroic and optical characterization of Dy doped BiFeO$_3$ multiferroic ceramic are presented. Bulk polycrystalline Bi$_{0.9}$Dy$_{0.1}$FeO$_3$ sample is synthesized by solid state reaction, while their nano counterparts are prepared using ultrasonic probe sonication technique.
arxiv +1 more source
Reference Based Color Transfer for Medical Volume Rendering [PDF]
arXiv, 2022 The benefits of medical imaging are enormous. Medical images provide considerable amounts of anatomical information and this facilitates medical practitioners in performing effective disease diagnosis and deciding upon the best course of medical treatment. A transition from traditional monochromatic medical images like CT scans, X-Rays or MRI images to
arxiv
Superconductivity at 33 - 37 K in $ALn_2$Fe$_4$As$_4$O$_2$ ($A$ = K and Cs; $Ln$ = Lanthanides) [PDF]
Phys. Rev. Materials 1, 044804 (2017), 2017 We have synthesized 10 new iron oxyarsenides, K$Ln_2$Fe$_4$As$_4$O$_2$ ($Ln$ = Gd, Tb, Dy, and Ho) and Cs$Ln_2$Fe$_4$As$_4$O$_2$ ($Ln$ = Nd, Sm, Gd, Tb, Dy, and Ho), with the aid of lattice-match [between $A$Fe$_2$As$_2$ ($A$ = K and Cs) and $Ln$FeAsO] approach. The resultant compounds possess hole-doped conducting double FeAs layers, [$A$Fe$_4$As$_4$]$
arxiv +1 more source
FoxO1 signaling in B cell malignancies and its therapeutic targeting
FEBS Letters, EarlyView.FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac +3 more
wiley +1 more source